The Georgia Institute of Technology Center for Inclusive Tech Design & Innovation presents a new event in their webinar series on COVID-19 Accessible Materials for People with Disabilities.
FAQs About COVID-19 Vaccines that People with Disabilities Should Consider
Wednesday, May 26, at 3:00 PM ET
COVID-19 vaccines are important tools to reduce the spread of COVID-19, especially for people with disabilities. The Centers for Disease Control and Prevention (CDC) recommends that anyone eligible to receive a COVID-19 vaccine should get it, as well as continue to follow safety precautions like wearing a mask, washing hands, and avoiding crowds. Come hear frequently asked questions (FAQs) about COVID-19 vaccines that people with disabilities should consider. This webinar will outline the CDC guidelines, as well as explore solutions to challenges people with disabilities may experience regarding accessing COVID-19 vaccines, like making an appointment for vaccination. Participants will receive tips, resources, and guidance regarding the available vaccines as we collectively navigate this challenging time.
Early registration is required. Registration closes 1 hour before the live webinar begins.
Webinars are presented through Zoom. Captions and American Sign Language will be available. All webinars are recorded and the archive, transcript, accessible presentation, as well as additional handouts will be made available within one week of the live webinar.
If you missed any of previous webinars in the COVID-19 Accessible Materials for People with Disabilities Project, visit their webinar archive at https://cidi.gatech.edu/covid/training for broadcast recordings, live transcripts, and other support documents.
For questions about this webinar or if you would like more information about the COVID-19 Accessible Materials for People with Disabilities Project, please contact email@example.com.
This webinar series is made possible due to funding from the CDC Foundation along with technical assistance from the Centers for Disease Control and Prevention.